nocturnal enuresis. Nonorganic enuresis
Conditions
Interventions
Intervention 1: intervention group1: vitamin D3 supplement 1000 IU,1 tablet per day during 2 months and omega3 placebo capsule,1 capsule per day for 2 months. Intervention 2: Intervention group 3: vi
Treatment - Drugs
intervention group1: vitamin D3 supplement 1000 IU,1 tablet per day during 2 months and omega3 placebo capsule,1 capsule per day for 2 months
Intervention group 3: vitamin D3 supplement 1000 IU,1 tablet per day during 2 months and omega3 supplement 1000 mg , 1 capsule per day for 2 months
control group: placebo tablets of vitamin D3 ,1 tablet per day for 2 months and placebo capsule of omega 3 , 1 capsule per day for 2 months
Intervention group 2: omega3 supplement 1000 mg , 1 capsule per day for 2 months and vitamin d3 placebo tablet 1 tablet per day for 2 month
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
7 Years to 15 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 7-15; the tendency of parents to participate in the project and signing the consent form; the diagnosis of enuresis in child exclusion criteria: high serum calcium; high ratio of urine calcium to creatinin ; diabetics;
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nocturnal enuresis. Timepoint: every week during 2 months intervention. Method of measurement: Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum 1,25 (OH)2 vitaminD level. Timepoint: before study and at the end of study. Method of measurement: blood test.;Urine prostaglandin E2 level. Timepoint: before and after intervention. Method of measurement: urine test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactElham Rahmani
School Of Nutrition and Food Science
Outcome results
None listed